SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is trending due to its upcoming earnings report, with the community split between bullish and bearish sentiment, while many express concerns about the company's high valuation and lack of current revenue. Community members are actively discussing potential price movements post-earnings, insider selling, and the overall viability of Oklo's long-term prospects in the nuclear energy sector.

Leifras Co., Ltd. Engages in sport training, event and alliance & club activity support and healthcare activities. It provides services related to the organization and operations of sports schools and sports events for children and it also operate a robust social business sector, dispatching sports coaches to meet various community needs. The company was founded by Kiyotaka Ito on August 28, 2001 and is headquartered in Tokyo, Japan.

Leifras Co Ltd - ADR

LEIFRAS Co., Ltd. American Depositary Shares

Shares of LFS are surging, driven by excitement around its low float and potential for a short squeeze, reminiscent of other recent IPOs. Community members are actively discussing price targets and potential sympathy plays among Japanese stocks. Some traders caution about the risks associated with pump-and-dump schemes and recent IPOs, while others highlight positive financials and growth potential.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

NBIS is trending amidst discussions about its earnings report and a new $3B Meta deal, though revenue slightly missed estimates, sparking mixed reactions. Community members are weighing the significance of capacity constraints and a potential ATM offering, while others debate the long-term prospects of AI infrastructure plays and compare NBIS to competitors like CRWV. Overall sentiment seems divided between bullish conviction in long-term growth and concerns about short-term volatility and dilution.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending as a bidding war with Novo Nordisk for Metsera intensifies, with community members speculating on potential outcomes and impacts on PFE's strategy in the growing weight-loss market. Some traders are noting high call option activity and significant volume, while others express skepticism, citing past performance and leadership concerns. Discussions also touch on the potential for sector rotation and the stock's undervaluation compared to competitors like Eli Lilly.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is trending amid unconfirmed speculation that the company is in talks to be acquired, driving significant trading volume. The community is discussing potential buyout prices and who the acquirer might be, with some suggesting Merck due to existing partnerships. Short squeeze potential is also being debated given the stock's high short interest.

Galecto, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The firm is also involved in the development of small molecule inhibitors of galectin-3 and LOXL2. The company was founded by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye in 2011 and is headquartered in Boston, MA.

Galecto Inc

GLTO is trending due to a recent acquisition announcement, sparking significant interest and a massive price surge. The community is actively discussing the potential for a short squeeze, given the stock's low float and high short interest, with some speculating about further gains. Trading volume is exceptionally high as the stock experiences increased volatility.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is trending as the stock price rises following news of a large, performance-based compensation package for its CEO, drawing comparisons to Tesla's executive compensation model. The community is bullish, anticipating further gains and discussing potential price targets, while also debating the company's long-term potential in the EV market amid increasing competition. Some investors are expressing concerns about the CEO's compensation plan relative to the company's current financial performance.

XPeng, Inc. engages in the design, development, manufacture, and marketing of smart electric vehicles. Its products are environmentally friendly vehicles, namely an SUV (the G3) and a four-door sports sedan (the P7). It also provides a range of services to the clients, including supercharging service, maintenance service, ride-hailing service and vehicle leasing service. The company was founded by Xiao Peng He, Heng Xia, and Tao He in 2015 and is headquartered in Guangzhou, China.

XPeng Inc - ADR

XPEV is trending due to positive sentiment surrounding its expansion into new European markets and recent AI and robotics developments. Community members are discussing the potential for significant growth and profitability, drawing comparisons to Tesla's early stages. Bullish investors are pointing to the company's innovation in AI and robotics and strong revenue growth as reasons for optimism.

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.

Anavex Life Sciences Corporation

Anavex Life Sciences Corp

AVXL is trending amid anticipation for potential news regarding its Alzheimer's drug, Blarcamesine, as the company prepares for an oral explanation with the CHMP this week. Community discussions revolve around the potential approval outcomes and the impact on the stock, with some investors expressing concerns about short selling and manipulation while others remain optimistic about the drug's prospects in the European market given Blarcamesine's potential benefits over existing treatments.

Venture Global, Inc. engages in the development and construction of liquefied natural gas production, establishing us as a rapidly growing company delivering critical LNG to the world. It projects include Calcasieu, Plaquemines, CP2, CP3 and Delta projects. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global ($VG) is trending due to arbitration issues with major energy firms like Shell and BP, creating uncertainty around its financial obligations and contract fulfillment. The community is actively discussing the potential impact of these legal battles on the company's future, with some seeing it as a buying opportunity amidst the volatility and others expressing concern about the stock's performance. Despite the negative news, some investors believe the company's growth potential in the LNG market remains strong, particularly with increasing global demand and the expansion of its facilities.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

AMA announcement 📣 

Excited about the Monday opening ? 

$NIFTY50.NSE and $NIFTYBANK.NSE opened up with a booster but have resisted exactly at 10 day average which was acting as support for the last 3 months. Secondly, Futures are also trading in discount…

So is your portfolio not performing even after such an open, then shoot up your queries and I shall recommend you the best strategy at CMP!!!

 
$ASK.P

Junaid Khan

Vipul H. Ramaiya CMT CFTe

Rajni Murugan

Shiv Sharma

Stocktwits India

Khushbu Balwani

Your portfolio not performing? Curious to know what lies ahead for your stocks in your portfolio? Here&#39;s @Kushghodasara hosting an AMA and sharing his views 👇 Go ahead, and drop your queries in his comments below!! 
 
$NIFTY50.NSE $NIFTYBANK.NSE $ASK.P

StockTwits Web

StockTwits for iOS

Ask The Community

AMA announcement 📣 

Excited about the Monday opening ? 



 opened up with a booster but have resisted exactly at 10 day average which was acting as support for the last 3 months. Secondly, Futures are also trading in discount…

So is your portfolio not performing even after such an open, then shoot up your queries and I shall recommend you the best strategy at CMP!!!

 


This account has been verified as a SEBI Research Analyst (RA).

Verified SEBI RA Account

Kush Ghodasara, CMT

@Kushghodasara  Sir, I have invested in IT stocks for long term perspective as I am 18 years old. Should I hold those stocks or I move to another sector stocks as I have no responsibilities so I am an aggressive investor $Suggestme

StockTwits For Android 

  Sir, I have invested in IT stocks for long term perspective as I am 18 years old. Should I hold those stocks or I move to another sector stocks as I have no responsibilities so I am an aggressive investor $Suggestme

@Kushghodasara please share your views on $BSE.NSE  on this level can we invest for longterm with bulk investment? $Suggestme

BSE Ltd

BSE is trending due to strong Q2FY26 results, with significant YoY growth in net profit, revenue, and EBITDA margins, exceeding estimates. Community discussions highlight the stock's breakout above key resistance levels, signaling bullish continuation and potential for further upside. Positive factors include revenue growth, margin expansion, and investments in technology, while risk factors involve declining investment and other income.

  on this level can we invest for longterm with bulk investment? $Suggestme

@Syblus Sir IT stocks are good to invest for long term and i appreciate that you started investing at young age.... 
 
But i believe selection of IT stocks is crucial... 
 
i Believe old school stocks like $INFY.NSE $TCS.NSE $WIPRO.NSE  will give return but not 2x or 3x.....Invest in new edge IT Stocks like $ZOMATO.NSE $NAUKRI.NSE $HAPPSTMNDS.NSE $BHARTIARTL.NSE .... 
 
Try to identify stocks of the services which has highest user base...which is GENZ or GEN ALPHA of indian population.

Mohammad Ashhad

Bharti Airtel Ltd.

Infosys Ltd

Wipro Ltd.

Eternal Ltd.

Info Edge (India) Ltd.

Happiest Minds Technologies Ltd.

 Sir IT stocks are good to invest for long term and i appreciate that you started investing at young age.... 
 
But i believe selection of IT stocks is crucial... 
 
i Believe old school stocks like 

  will give return but not 2x or 3x.....Invest in new edge IT Stocks like $ZOMATO.NSE 

 .... 
 
Try to identify stocks of the services which has highest user base...which is GENZ or GEN ALPHA of indian population.

@Khushbu_Balwani  $BSE.NSE Good stock selected... Stock exchanges in INDIA is a Duo poly market which means they have a great market share... Secondly, stock market is every day business and for exchanges its always WIN- WIN. 
 
Talking technically, for now stock has strong support at 2700... I Would suggest in parts....Invest 50% for the capital right now....Rest  50% you can invest in next quarter......  $ASK.P us in next quarters AMA.

 Good stock selected... Stock exchanges in INDIA is a Duo poly market which means they have a great market share... Secondly, stock market is every day business and for exchanges its always WIN- WIN. 
 
Talking technically, for now stock has strong support at 2700... I Would suggest in parts....Invest 50% for the capital right now....Rest  50% you can invest in next quarter......  

@Kushghodasara Sir, I am badly stuck with stocks like $BALPHARMA.NSE $SUZLON.NSE $BSOFT.NSE with loss of 20% in each, holding from past 2.5 months. What should I do? $Suggestme

Birlasoft Ltd.

Suzlon Energy Ltd.

Bal Pharma Ltd.

 with loss of 20% in each, holding from past 2.5 months. What should I do? $Suggestme

@Khushbu_Balwani What your horizon for holding?? Long term or was it for short term trading?

 What your horizon for holding?? Long term or was it for short term trading?

@Kushghodasara Sir it was short-term like for 4-6 months.

 Sir it was short-term like for 4-6 months.

@Khushbu_Balwani First of all , I don&#39;t believe in short term trading in mid cap stocks because they perform in short term only when market is in upside momentum...and such cases are only few months during a 8 years rally.....So next time if you want to trade for short term, stick to NIFTY 200 stocks because if you are trapped at higher price, atleast you get a better chance to exit than in midcap... 
 
Anyways ... 
 
$SUZLON.NSE is currently looking good with stop loss at 40.20 and tgt 47 in few weeks. 
 
$BSOFT.NSE is looking weak until it cross 720...Stock could test 200 day average support at 620 .... 
 
$BALPHARMA.NSE looks weak too and its resisting at 200 day average at 103...look weak in short term!!!!

Desi Bull Street

 First of all , I don't believe in short term trading in mid cap stocks because they perform in short term only when market is in upside momentum...and such cases are only few months during a 8 years rally.....So next time if you want to trade for short term, stick to NIFTY 200 stocks because if you are trapped at higher price, atleast you get a better chance to exit than in midcap... 
 
Anyways ... 
 


 is currently looking good with stop loss at 40.20 and tgt 47 in few weeks. 
 


 is looking weak until it cross 720...Stock could test 200 day average support at 620 .... 
 


 looks weak too and its resisting at 200 day average at 103...look weak in short term!!!!

@Kushghodasara Sir I have seen Many DIIs are increasing their stake in API companies like $GRANULES.NSE or $DIVISLAB.NSE  or $AUROPHARMA.NSE or $ZYDUSLIFE.NSE very fastly instead these companies results are not so good and stocks are not performing in 3yr time frame. Is their any possibility of rally in these stocks this year, why are DIIs taking stakes in these companies? More importantly, should I invest

Divi`s Laboratories Ltd.

Zydus Lifesciences Ltd.

Aurobindo Pharma Ltd.

Granules India Ltd.

 Sir I have seen Many DIIs are increasing their stake in API companies like 

 very fastly instead these companies results are not so good and stocks are not performing in 3yr time frame. Is their any possibility of rally in these stocks this year, why are DIIs taking stakes in these companies? More importantly, should I invest

@Syblus Frankly speaking i dont directly invest in Pharma stocks because its impossible for a common man to predict which medicine sales would rise...We cant predict diseases... 
 
So i believe to invest in PHARMA Thematic Fund in SIP mode.... I suggest TATA PHARMA FUND

 Frankly speaking i dont directly invest in Pharma stocks because its impossible for a common man to predict which medicine sales would rise...We cant predict diseases... 
 
So i believe to invest in PHARMA Thematic Fund in SIP mode.... I suggest TATA PHARMA FUND

@Kushghodasara share your views on caspian . How to exit

 share your views on caspian . How to exit

Sumitmulani

@Kushghodasara sir I am stuck in tv18, paytm, easemytrip, epack very badly 10-30% down should I average it at this level

 sir I am stuck in tv18, paytm, easemytrip, epack very badly 10-30% down should I average it at this level

HEMISH SHAH

@Hemishshah  
 
$TV18BRDCST.NSE is low volume item and it hasnt ever performed for investors....I would strictly avoid media sector for long term because now OTT is taking over larger market share of ad revenues ..... So book loss is my advise 
 
$PAYTM.NSE IPO was a trap for investors..... They are jack off all , master of none...with UPI picking up, wallet literally doesnt make any sense....and other third party services are with low margins...So book loss at the earlies... 
 
$EASEMYTRIP.NSE is a 5 years + investment stock...Buy on dips with stop loss at 37 for targets of 120+++..... It is the only start up which is in profit YoY basis since its inception in 2008..... and its largest indian travel portal and second largest after Make my trip in india....

@Kushghodasara continues to share his views on the markets 🤓  
 
Have a query on your fav stocks? Go ahead, and drop your queries in this thread 👇 
 
$PAYTM.NSE $TV18BRDCST.NSE $EASEMYTRIP.NSE $NIFTY50.NSE $NIFTYBANK.NSE

One 97 Communications Ltd.

TV18 Broadcast Ltd

Easy Trip Planners Limited

 is low volume item and it hasnt ever performed for investors....I would strictly avoid media sector for long term because now OTT is taking over larger market share of ad revenues ..... So book loss is my advise 
 


 IPO was a trap for investors..... They are jack off all , master of none...with UPI picking up, wallet literally doesnt make any sense....and other third party services are with low margins...So book loss at the earlies... 
 


 is a 5 years + investment stock...Buy on dips with stop loss at 37 for targets of 120+++..... It is the only start up which is in profit YoY basis since its inception in 2008..... and its largest indian travel portal and second largest after Make my trip in india....

@Kushghodasara thanks for all that one more script view I wanted # hfcl

 thanks for all that one more script view I wanted # hfcl